You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 116 No. 6, June 1980 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Acyclovir Topical Therapy of Cutaneous Herpes Simplex Virus Infection in Guinea Pigs

No-Hee Park, DDS, PhD; Deborah Pavan-Langston, MD; Sandra L. McLean; Jonathan H. Lass, MD

Arch Dermatol. 1980;116(6):672-675.


Abstract



• The chemotherapeutic efficacy of acyclovir was evaluated by observing the potential of topical acyclovir to reduce the severity of herpes viral lesions and to control the multiplication of this virus in the experimentally induced primary cutaneous infection of guinea pigs. Topical acyclovir showed a substantially high therapeutic efficacy when treatment was initiated after the development of clinically overt skin lesions. The therapeutic response was dose dependent and clearly evident even when the treatment was initiated on day 2 after inoculation. Our results indicate that topical acyclovir treatment improved the cutaneous herpes simplex virus type 1 (HSV-1) infectious process by inhibiting multiplication of HSV-1 in the skin of guinea pigs.

(Arch Dermatol 116:672-675, 1980)



Author Affiliations



From the Department of Cornea Research, Eye Research Institute of Retina Foundation (Drs Park, Pavan-Langston, and Lass, and Ms McLean) and the Department of Ophthalmology, Harvard Medical School (Drs Park, Pavan-Langston, and Lass), Boston.


Footnotes



Accepted for publication Oct 8, 1979.

Reprint requests to the Department of Cornea Research, Eye Research Institute of Retina Foundation, 20 Staniford St, Boston, MA 02114 (Dr Park).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Herpes Simplex Acyclovir-Resistant Mutant in Experimental Keratouveitis
Boisjoly et al.
Arch Ophthalmol 1983;101:1782-1786.
ABSTRACT  

Treatment of Eczema Herpeticum With Acyclovir
Swart et al.
Arch Dermatol 1983;119:13-16.
ABSTRACT  

Acyclovir Therapy for the Orofacial and Ganglionic HSV Infection in Hairless Mice
Park et al.
JDR 1980;59:2080-2086.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.